Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
Line 2,218: Line 2,218:


==WHO Central Nervous System Tumours  (5th ed.) Content==
==WHO Central Nervous System Tumours  (5th ed.) Content==
{| class="wikitable"
| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
Line 2,227: Line 2,227:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|-|Astrocytoma, IDH-mutant||Disease||
| Astrocytoma, IDH-mutant||Disease||
|
|
|
|
Line 2,237: Line 2,236:
|
|
|-
|-
| Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted||Disease||
|
|
|
|
Line 2,246: Line 2,245:
|
|
|-
|-
| Glioblastoma, IDH-wildtype||Disease||
|Glioblastoma, IDH-wildtype||Disease||
|
|
|
|
Line 2,255: Line 2,254:
|
|
|-
|-
| Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
|Diffuse astrocytoma, MYB- or MYBL1-altered||Disease||
|
|
|
|
Line 2,264: Line 2,263:
|
|
|-
|-
| Angiocentric glioma||Disease||
|Angiocentric glioma||Disease||
|
|
|
|
Line 2,273: Line 2,272:
|
|
|-
|-
| Polymorphous low-grade neuroepithelial tumour of the young||Disease||
|Polymorphous low-grade neuroepithelial tumour of the young||Disease||
|
|
|
|
Line 2,282: Line 2,281:
|
|
|-
|-
| Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
|Diffuse low-grade glioma, MAPK pathway-altered ||Disease||
|
|
|
|
Line 2,291: Line 2,290:
|
|
|-
|-
| Diffuse midline glioma, H3 K27-altered||Disease||
|Diffuse midline glioma, H3 K27-altered||Disease||
|
|
|
|
Line 2,300: Line 2,299:
|
|
|-
|-
| Diffuse hemispheric glioma, H3 G34-mutant||Disease||
|Diffuse hemispheric glioma, H3 G34-mutant||Disease||
|
|
|
|
Line 2,309: Line 2,308:
|
|
|-
|-
| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype||Disease||
|
|
|
|
Line 2,318: Line 2,317:
|
|
|-
|-
| Infant-type hemispheric glioma||Disease||
|Infant-type hemispheric glioma||Disease||
|
|
|
|
Line 2,327: Line 2,326:
|
|
|-
|-
| Pilocytic astrocytoma ||Disease||
|Pilocytic astrocytoma ||Disease||
|
|
|
|
Line 2,336: Line 2,335:
|
|
|-
|-
| High-grade astrocytoma with piloid features||Disease||
|High-grade astrocytoma with piloid features||Disease||
|
|
|
|
Line 2,345: Line 2,344:
|
|
|-
|-
| Pleomorphic xanthoastrocytoma||Disease||
|Pleomorphic xanthoastrocytoma||Disease||
|
|
|
|
Line 2,354: Line 2,353:
|
|
|-
|-
| Subependymal giant cell astrocytoma||Disease||
|Subependymal giant cell astrocytoma||Disease||
|
|
|
|
Line 2,363: Line 2,362:
|
|
|-
|-
| Chordoid glioma||Disease||
|Chordoid glioma||Disease||
|
|
|
|
Line 2,372: Line 2,371:
|
|
|-
|-
| Astroblastoma, MN1-altered||Disease||
|Astroblastoma, MN1-altered||Disease||
|
|
|
|
Line 2,381: Line 2,380:
|
|
|-
|-
| Ganglioglioma||Disease||
|Ganglioglioma||Disease||
|
|
|
|
Line 2,390: Line 2,389:
|
|
|-
|-
| Gangliocytoma||Disease||
|Gangliocytoma||Disease||
|
|
|
|
Line 2,399: Line 2,398:
|
|
|-
|-
| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma||Disease||
|
|
|
|
Line 2,408: Line 2,407:
|
|
|-
|-
| Dysembryoplastic neuroepithelial tumour||Disease||
|Dysembryoplastic neuroepithelial tumour||Disease||
|
|
|
|
Line 2,417: Line 2,416:
|
|
|-
|-
| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters||Disease||
|
|
|
|
Line 2,426: Line 2,425:
|
|
|-
|-
| Papillary glioneuronal tumour||Disease||
|Papillary glioneuronal tumour||Disease||
|
|
|
|
Line 2,435: Line 2,434:
|
|
|-
|-
| Rosette-forming glioneuronal tumour||Disease||
|Rosette-forming glioneuronal tumour||Disease||
|
|
|
|
Line 2,444: Line 2,443:
|
|
|-
|-
| Myxoid glioneuronal tumour||Disease||
|Myxoid glioneuronal tumour||Disease||
|
|
|
|
Line 2,453: Line 2,452:
|
|
|-
|-
| Diffuse leptomeningeal glioneuronal tumour||Disease||
|Diffuse leptomeningeal glioneuronal tumour||Disease||
|
|
|
|
Line 2,462: Line 2,461:
|
|
|-
|-
| Multinodular and vacuolating neuronal tumour||Disease||
|Multinodular and vacuolating neuronal tumour||Disease||
|
|
|
|
Line 2,471: Line 2,470:
|
|
|-
|-
| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)||Disease||
|
|
|
|
Line 2,480: Line 2,479:
|
|
|-
|-
| Central neurocytoma||Disease||
|Central neurocytoma||Disease||
|
|
|
|
Line 2,489: Line 2,488:
|
|
|-
|-
| Extraventricular neurocytoma||Disease||
|Extraventricular neurocytoma||Disease||
|
|
|
|
Line 2,498: Line 2,497:
|
|
|-
|-
| Cerebellar liponeurocytoma||Disease||
|Cerebellar liponeurocytoma||Disease||
|
|
|
|
Line 2,507: Line 2,506:
|
|
|-
|-
| Supratentorial ependymoma||Disease||
|Supratentorial ependymoma||Disease||
|
|
|
|
Line 2,516: Line 2,515:
|
|
|-
|-
| Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
|Supratentorial ependymoma, ZFTA fusion-positive ||Disease||
|
|
|
|
Line 2,525: Line 2,524:
|
|
|-
|-
| Supratentorial ependymoma, YAP1 fusion-positive||Disease||
|Supratentorial ependymoma, YAP1 fusion-positive||Disease||
|
|
|
|
Line 2,534: Line 2,533:
|
|
|-
|-
| Posterior fossa ependymoma||Disease||
|Posterior fossa ependymoma||Disease||
|
|
|
|
Line 2,543: Line 2,542:
|
|
|-
|-
| Posterior fossa group A (PFA) ependymoma||Disease||
|Posterior fossa group A (PFA) ependymoma||Disease||
|
|
|
|
Line 2,552: Line 2,551:
|
|
|-
|-
| Posterior fossa group B (PFB) ependymoma||Disease||
|Posterior fossa group B (PFB) ependymoma||Disease||
|
|
|
|
Line 2,561: Line 2,560:
|
|
|-
|-
| Spinal ependymoma||Disease||
|Spinal ependymoma||Disease||
|
|
|
|
Line 2,570: Line 2,569:
|
|
|-
|-
| Spinal ependymoma, MYCN-amplified||Disease||
|Spinal ependymoma, MYCN-amplified||Disease||
|
|
|
|
Line 2,579: Line 2,578:
|
|
|-
|-
| Myxopapillary ependymoma||Disease||
|Myxopapillary ependymoma||Disease||
|
|
|
|
Line 2,588: Line 2,587:
|
|
|-
|-
| Subependymoma||Disease||
|Subependymoma||Disease||
|
|
|
|
Line 2,597: Line 2,596:
|
|
|-
|-
| Choroid plexus papilloma||Disease||
|Choroid plexus papilloma||Disease||
|
|
|
|
Line 2,606: Line 2,605:
|
|
|-
|-
| Atypical choroid plexus papilloma||Disease||
|Atypical choroid plexus papilloma||Disease||
|
|
|
|
Line 2,615: Line 2,614:
|
|
|-
|-
| Choroid plexus carcinoma||Disease||
|Choroid plexus carcinoma||Disease||
|
|
|
|
Line 2,624: Line 2,623:
|
|
|-
|-
| Medulloblastoma, WNT-activated||Disease||
|Medulloblastoma, WNT-activated||Disease||
|
|
|
|
Line 2,633: Line 2,632:
|
|
|-
|-
| Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
|Medulloblastoma, SHH-activated and TP53-wildtype||Disease||
|
|
|
|
Line 2,642: Line 2,641:
|
|
|-
|-
| Medulloblastoma, SHH-activated and TP53-mutant||Disease||
|Medulloblastoma, SHH-activated and TP53-mutant||Disease||
|
|
|
|
Line 2,651: Line 2,650:
|
|
|-
|-
| Medulloblastoma, non-WNT/non-SHH||Disease||
|Medulloblastoma, non-WNT/non-SHH||Disease||
|
|
|
|
Line 2,660: Line 2,659:
|
|
|-
|-
| Medulloblastoma, histologically defined||Disease||
|Medulloblastoma, histologically defined||Disease||
|
|
|
|
Line 2,669: Line 2,668:
|
|
|-
|-
| Atypical teratoid/rhabdoid tumour||Disease||
|Atypical teratoid/rhabdoid tumour||Disease||
|
|
|
|
Line 2,678: Line 2,677:
|
|
|-
|-
| Cribriform neuroepithelial tumour||Disease||
|Cribriform neuroepithelial tumour||Disease||
|
|
|
|
Line 2,687: Line 2,686:
|
|
|-
|-
| Embryonal tumour with multilayered rosettes||Disease||
|Embryonal tumour with multilayered rosettes||Disease||
|
|
|
|
Line 2,696: Line 2,695:
|
|
|-
|-
| CNS neuroblastoma, FOXR2-activated||Disease||
|CNS neuroblastoma, FOXR2-activated||Disease||
|
|
|
|
Line 2,705: Line 2,704:
|
|
|-
|-
| CNS tumour with BCOR internal tandem duplication||Disease||
|CNS tumour with BCOR internal tandem duplication||Disease||
|
|
|
|
Line 2,714: Line 2,713:
|
|
|-
|-
| CNS embryonal tumour NEC/NOS||Disease||
|CNS embryonal tumour NEC/NOS||Disease||
|
|
|
|
Line 2,723: Line 2,722:
|
|
|-
|-
| Pineocytoma||Disease||
|Pineocytoma||Disease||
|
|
|
|
Line 2,732: Line 2,731:
|
|
|-
|-
| Pineal parenchymal tumour of intermediate differentiation||Disease||
|Pineal parenchymal tumour of intermediate differentiation||Disease||
|
|
|
|
Line 2,741: Line 2,740:
|
|
|-
|-
| Pineoblastoma||Disease||
|Pineoblastoma||Disease||
|
|
|
|
Line 2,750: Line 2,749:
|
|
|-
|-
| Papillary tumour of the pineal region||Disease||
|Papillary tumour of the pineal region||Disease||
|
|
|
|
Line 2,759: Line 2,758:
|
|
|-
|-
| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant||Disease||
|
|
|
|
Line 2,768: Line 2,767:
|
|
|-
|-
| Schwannoma||Disease||
|Schwannoma||Disease||
|
|
|
|
Line 2,777: Line 2,776:
|
|
|-
|-
| Neurofibroma||Disease||
|Neurofibroma||Disease||
|
|
|
|
Line 2,786: Line 2,785:
|
|
|-
|-
| Perineurioma||Disease||
|Perineurioma||Disease||
|
|
|
|
Line 2,795: Line 2,794:
|
|
|-
|-
| Hybrid nerve sheath tumours||Disease||
|Hybrid nerve sheath tumours||Disease||
|
|
|
|
Line 2,804: Line 2,803:
|
|
|-
|-
| Malignant melanotic nerve sheath tumour||Disease||
|Malignant melanotic nerve sheath tumour||Disease||
|
|
|
|
Line 2,813: Line 2,812:
|
|
|-
|-
| Malignant peripheral nerve sheath tumour||Disease||
|Malignant peripheral nerve sheath tumour||Disease||
|
|
|
|
Line 2,822: Line 2,821:
|
|
|-
|-
| Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
|Cauda equina neuroendocrine tumour (previously paraganglioma)||Disease||
|
|
|
|
Line 2,831: Line 2,830:
|
|
|-
|-
| Meningioma||Disease||
|Meningioma||Disease||
|
|
|
|
Line 2,840: Line 2,839:
|
|
|-
|-
| Solitary fibrous tumour||Disease||
|Solitary fibrous tumour||Disease||
|
|
|
|
Line 2,849: Line 2,848:
|
|
|-
|-
| Haemangiomas and vascular malformations||Disease||
|Haemangiomas and vascular malformations||Disease||
|
|
|
|
Line 2,858: Line 2,857:
|
|
|-
|-
| Haemangioblastoma||Disease||
|Haemangioblastoma||Disease||
|
|
|
|
Line 2,867: Line 2,866:
|
|
|-
|-
| Rhabdomyosarcoma||Disease||
|Rhabdomyosarcoma||Disease||
|
|
|
|
Line 2,876: Line 2,875:
|
|
|-
|-
| Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
|Intracranial mesenchymal tumour, FET::CREB fusion-positive||Disease||
|
|
|
|
Line 2,885: Line 2,884:
|
|
|-
|-
| CIC-rearranged sarcoma||Disease||
|CIC-rearranged sarcoma||Disease||
|
|
|
|
Line 2,894: Line 2,893:
|
|
|-
|-
| Primary intracranial sarcoma, DICER1-mutant||Disease||
|Primary intracranial sarcoma, DICER1-mutant||Disease||
|
|
|
|
Line 2,903: Line 2,902:
|
|
|-
|-
| Ewing sarcoma||Disease||
|Ewing sarcoma||Disease||
|
|
|
|
Line 2,912: Line 2,911:
|
|
|-
|-
| Mesenchymal chondrosarcoma||Disease||
|Mesenchymal chondrosarcoma||Disease||
|
|
|
|
Line 2,921: Line 2,920:
|
|
|-
|-
| Chondrosarcoma||Disease||
|Chondrosarcoma||Disease||
|
|
|
|
Line 2,930: Line 2,929:
|
|
|-
|-
| Chordoma||Disease||
|Chordoma||Disease||
|
|
|
|
Line 2,939: Line 2,938:
|
|
|-
|-
| Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis||Disease||
|
|
|
|
Line 2,948: Line 2,947:
|
|
|-
|-
| Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma||Disease||
|
|
|
|
Line 2,957: Line 2,956:
|
|
|-
|-
| Primary diffuse large B-cell lymphoma of the CNS||Disease||
|Primary diffuse large B-cell lymphoma of the CNS||Disease||
|
|
|
|
Line 2,966: Line 2,965:
|
|
|-
|-
| Immunodeficiency-associated CNS lymphomas||Disease||
|Immunodeficiency-associated CNS lymphomas||Disease||
|
|
|
|
Line 2,975: Line 2,974:
|
|
|-
|-
| Lymphomatoid granulomatosis||Disease||
|Lymphomatoid granulomatosis||Disease||
|
|
|
|
Line 2,984: Line 2,983:
|
|
|-
|-
| Intravascular large B-cell lymphoma||Disease||
|Intravascular large B-cell lymphoma||Disease||
|
|
|
|
Line 2,993: Line 2,992:
|
|
|-
|-
| MALT lymphoma of the dura||Disease||
|MALT lymphoma of the dura||Disease||
|
|
|
|
Line 3,002: Line 3,001:
|
|
|-
|-
| Other low-grade B-cell lymphomas of the CNS||Disease||
|Other low-grade B-cell lymphomas of the CNS||Disease||
|
|
|
|
Line 3,011: Line 3,010:
|
|
|-
|-
| Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
|Anaplastic large cell lymphoma (ALK+/ALK−)||Disease||
|
|
|
|
Line 3,020: Line 3,019:
|
|
|-
|-
| T-cell and NK/T-cell lymphomas||Disease||
|T-cell and NK/T-cell lymphomas||Disease||
|
|
|
|
Line 3,029: Line 3,028:
|
|
|-
|-
| Erdheim-Chester disease||Disease||
|Erdheim-Chester disease||Disease||
|
|
|
|
Line 3,038: Line 3,037:
|
|
|-
|-
| Rosai-Dorfman disease||Disease||
|Rosai-Dorfman disease||Disease||
|
|
|
|
Line 3,047: Line 3,046:
|
|
|-
|-
| Juvenile xanthogranuloma||Disease||
|Juvenile xanthogranuloma||Disease||
|
|
|
|
Line 3,056: Line 3,055:
|
|
|-
|-
| Langerhans cell histiocytosis||Disease||
|Langerhans cell histiocytosis||Disease||
|
|
|
|
Line 3,065: Line 3,064:
|
|
|-
|-
| Histiocytic sarcoma||Disease||
|Histiocytic sarcoma||Disease||
|
|
|
|
Line 3,074: Line 3,073:
|
|
|-
|-
| Germ cell tumours of the CNS||Disease||
|Germ cell tumours of the CNS||Disease||
|
|
|
|
Line 3,083: Line 3,082:
|
|
|-
|-
| Adamantinomatous craniopharyngioma||Disease||
|Adamantinomatous craniopharyngioma||Disease||
|
|
|
|
Line 3,092: Line 3,091:
|
|
|-
|-
| Papillary craniopharyngioma||Disease||
|Papillary craniopharyngioma||Disease||
|
|
|
|
Line 3,101: Line 3,100:
|
|
|-
|-
| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma||Disease||
|
|
|
|
Line 3,110: Line 3,109:
|
|
|-
|-
| Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
|Pituitary adenoma / pituitary neuroendocrine tumour||Disease||
|
|
|
|
Line 3,119: Line 3,118:
|
|
|-
|-
| Pituitary blastoma||Disease||
|Pituitary blastoma||Disease||
|
|
|
|
Line 3,128: Line 3,127:
|
|
|-
|-
| Metastases to the brain and spinal cord parenchyma||Disease||
|Metastases to the brain and spinal cord parenchyma||Disease||
|
|
|
|
Line 3,137: Line 3,136:
|
|
|-
|-
| Metastases to the meninges||Disease||
|Metastases to the meninges||Disease||
|
|
|
|
Line 3,146: Line 3,145:
|
|
|-
|-
| Neurofibromatosis type 1||Disease||
|Neurofibromatosis type 1||Disease||
|
|
|
|
Line 3,155: Line 3,154:
|
|
|-
|-
| Neurofibromatosis type 2||Disease||
|Neurofibromatosis type 2||Disease||
|
|
|
|
Line 3,164: Line 3,163:
|
|
|-
|-
| Schwannomatosis||Disease||
|Schwannomatosis||Disease||
|
|
|
|
Line 3,173: Line 3,172:
|
|
|-
|-
| Von Hippel-Lindau syndrome||Disease||
|Von Hippel-Lindau syndrome||Disease||
|
|
|
|
Line 3,182: Line 3,181:
|
|
|-
|-
| Tuberous sclerosis||Disease||
|Tuberous sclerosis||Disease||
|
|
|
|
Line 3,191: Line 3,190:
|
|
|-
|-
| Li-Fraumeni syndrome||Disease||
|Li-Fraumeni syndrome||Disease||
|
|
|
|
Line 3,200: Line 3,199:
|
|
|-
|-
| Cowden syndrome||Disease||
|Cowden syndrome||Disease||
|
|
|
|
Line 3,209: Line 3,208:
|
|
|-
|-
| Constitutional mismatch repair deficiency syndrome||Disease||
|Constitutional mismatch repair deficiency syndrome||Disease||
|
|
|
|
Line 3,218: Line 3,217:
|
|
|-
|-
| Familial adenomatous polyposis 1||Disease||
|Familial adenomatous polyposis 1||Disease||
|
|
|
|
Line 3,227: Line 3,226:
|
|
|-
|-
| Naevoid basal cell carcinoma syndrome||Disease||
|Naevoid basal cell carcinoma syndrome||Disease||
|
|
|
|
Line 3,236: Line 3,235:
|
|
|-
|-
| Rhabdoid tumour predisposition syndrome||Disease||
|Rhabdoid tumour predisposition syndrome||Disease||
|
|
|
|
Line 3,245: Line 3,244:
|
|
|-
|-
| Carney complex||Disease||
|Carney complex||Disease||
|
|
|
|
Line 3,254: Line 3,253:
|
|
|-
|-
| DICER1 syndrome||Disease||
|DICER1 syndrome||Disease||
|
|
|
|
Line 3,263: Line 3,262:
|
|
|-
|-
| Familial paraganglioma syndromes||Disease||
|Familial paraganglioma syndromes||Disease||
|
|
|
|
Line 3,272: Line 3,271:
|
|
|-
|-
| Melanoma-astrocytoma syndrome||Disease||
|Melanoma-astrocytoma syndrome||Disease||
|
|
|
|
Line 3,281: Line 3,280:
|
|
|-
|-
| Familial retinoblastoma||Disease||
|Familial retinoblastoma||Disease||
|
|
|
|
Line 3,290: Line 3,289:
|
|
|-
|-
| BAP1 tumour predisposition syndrome||Disease||
|BAP1 tumour predisposition syndrome||Disease||
|
|
|
|
Line 3,299: Line 3,298:
|
|
|-
|-
| Fanconi anaemia||Disease||
|Fanconi anaemia||Disease||
|
|
|
|
Line 3,308: Line 3,307:
|
|
|-
|-
| ELP1-medulloblastoma syndrome||Disease||
|ELP1-medulloblastoma syndrome||Disease||
|
|
|
|